{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:06:04Z","timestamp":1792638364984,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbi.2026.106957","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T21:58:16Z","timestamp":1786917496000},"page":"106957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A Delphi-method-based consensus for clinical domains and assessment of the inflammatory subtype of major depressive disorder from the ASPIRE study"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0748-4656","authenticated-orcid":false,"given":"Benedetta","family":"Vai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Cazzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Monopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Bravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Kontogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Wessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Worrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard T.","family":"Baune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Van der Eycken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Felger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Lamers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanni-Laura","family":"M\u00e4ntyl\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda W.J.H.","family":"Penninx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Sforzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bavato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Borsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Branchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucile","family":"Capuron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier R.","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartholomeus C.M.","family":"Haarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiste","family":"Lengvenyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele F.","family":"Osimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Otte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Eiel","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine M.","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia De","family":"Picker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2026.106957_b0080","unstructured":"European Medicines Agency. (2025). Guideline on clinical investigation of medicinal products in the treatment of depression."},{"key":"10.1016\/j.bbi.2026.106957_b0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","article-title":"Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME Consortium","volume":"10","author":"Arteaga-Henr\u00edquez","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.bbi.2026.106957_b0005","unstructured":"American Psychiatric Association. (1987). Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R. (3rd ed., rev.)."},{"key":"10.1016\/j.bbi.2026.106957_b0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2021.07.092","article-title":"No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: a 6-week double-blind placebo controlled randomized trial","volume":"53","author":"Baune","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2026.106957_b0020","doi-asserted-by":"crossref","unstructured":"Beck, A. T., Steer, R. A., & Brown, G. (1996). Beck depression inventory\u2013II.","DOI":"10.1037\/t00742-000"},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0025","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/wps.21110","article-title":"Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management","volume":"22","author":"Berk","year":"2023","journal-title":"World Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2026.106957_b0030","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jval.2019.02.010","article-title":"Symptoms of Major Depressive Disorder Scale: performance of a novel patient-reported symptom measure","volume":"22","author":"Bushnell","year":"2019","journal-title":"Value Health"},{"issue":"10","key":"10.1016\/j.bbi.2026.106957_b0035","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1200\/JCO.2000.18.10.2143","article-title":"Early depressive symptoms in cancer patients receiving interleukin 2 and\/or interferon alfa-2b therapy","volume":"18","author":"Capuron","year":"2000","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2003.11.004","article-title":"Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and\/or interferon-alpha cancer therapy","volume":"18","author":"Capuron","year":"2004","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1192\/bjp.2018.66","article-title":"Treatment-resistant depression and peripheral C-reactive protein","volume":"214","author":"Chamberlain","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106957_b0050","first-page":"458","volume":"9","author":"Dalkey","year":"1963","journal-title":"An experimental application of the Delphi method to the use of experts."},{"issue":"2","key":"10.1016\/j.bbi.2026.106957_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2026.106957_b0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.bbi.2023.07.023","article-title":"TSPO PET brain inflammation imaging: a transdiagnostic systematic review and meta-analysis of 156 case-control studies","volume":"113","author":"De Picker","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106957_b0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","article-title":"Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue","volume":"81","author":"Enache","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.bbi.2026.106957_b0085","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mp.2015.168","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","volume":"21","author":"Felger","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12916-017-0849-x","article-title":"The new field of \u2018precision psychiatry\u2019","volume":"15","author":"Fernandes","year":"2017","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.bbi.2026.106957_b0095","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","article-title":"Consensus methods: characteristics and guidelines for use","volume":"74","author":"Fink","year":"1984","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.bbi.2026.106957_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpnec.2021.100079","article-title":"Clinical phenotypes of depressed patients with evidence of inflammation and somatic symptoms","volume":"8","author":"Foley","year":"2021","journal-title":"Comprehensive Psychoneuroendocrinol."},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0105","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41380-022-01919-7","article-title":"Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis","volume":"28","author":"Foley","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106957_b0110","unstructured":"Food and Drug Administration. (2018). Major depressive disorder: developing drugs for treatment, Guidance for Industry\u2019, Draft Guidance."},{"issue":"12","key":"10.1016\/j.bbi.2026.106957_b0115","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1176\/appi.ajp.2021.20121776","article-title":"Association between systemic inflammation and individual symptoms of depression: a pooled analysis of 15 population-based cohort studies","volume":"178","author":"Frank","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106957_b0120","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jad.2019.05.029","article-title":"Corrigendum to \u201cthe 52 symptoms of major depression: lack of content overlap among seven common depression scales\u201d, [Journal of Affective Disorders, 208, 191\u2013197]","volume":"260","author":"Fried","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.bbi.2026.106957_b0125","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2026.106957_b0130","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/ibd.20873","article-title":"Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management","volume":"15","author":"Graff","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbi.2026.106957_b0135","first-page":"56","volume":"23","author":"Hamilton","year":"1960","journal-title":"A rating scale for depression."},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2026.106957_b0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psyneuen.2018.05.026","article-title":"Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder","volume":"95","author":"Haroon","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.bbi.2026.106957_b0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamapsychiatry.2025.0206","article-title":"Should inflammation be a specifier for major depression in the DSM-6?","volume":"82","author":"Jha","year":"2025","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jamapsychiatry.2015.1977","article-title":"Inflammation and specific symptoms of depression","volume":"73","author":"Jokela","year":"2016","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2026.106957_b0160","doi-asserted-by":"crossref","unstructured":"Kappelmann, N., Czamara, D., Rost, N., Moser, S., Schmoll, V., Trastulla, L., Stochl, J., CHARGE Inflammation Working Group, Binder, E. B., Khandaker, G. M., Arloth, J. (2021). Polygenic risk for immuno-metabolic markers and specific depressive symptoms: a multi-sample network analysis study. Brain, Behavior, and Immunity, 95, 256\u2013268. https:\/\/doi.org\/10.1016\/j.bbi.2021.03.024..","DOI":"10.1016\/j.bbi.2021.03.024"},{"issue":"9","key":"10.1016\/j.bbi.2026.106957_b0165","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/jnc.15946","article-title":"Inflammation\u2010stratified augmentation of vortioxetine with celecoxib: results from a double\u2010blind, randomized, placebo\u2010controlled trial in major depressive disorder","volume":"168","author":"Kavakbasi","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2026.106957_b0175","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbi.2017.02.020","article-title":"Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression","volume":"62","author":"K\u00f6hler-Forsberg","year":"2017","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"10.1016\/j.bbi.2026.106957_b0180","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/acps.13016","article-title":"Efficacy of anti\u2010inflammatory treatment on major depressive disorder or depressive symptoms: meta\u2010analysis of clinical trials","volume":"139","author":"K\u00f6hler-Forsberg","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2026.106957_b0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbi.2020.04.002","article-title":"Depression profilers and immuno-metabolic dysregulation: longitudinal results from the NESDA study","volume":"88","author":"Lamers","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaad.2009.09.014","article-title":"Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"63","author":"Langley","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0195","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41398-025-03372-w","article-title":"Role of inflammation in depressive and anxiety disorders, affect, and cognition: genetic and non-genetic findings in the Lifelines cohort study","volume":"15","author":"Mac Giollabhui","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106957_b0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychores.2017.07.015","article-title":"Increased incidence of psychiatric disorders in immune-mediated inflammatory disease","volume":"101","author":"Marrie","year":"2017","journal-title":"J. Psychosom. Res."},{"issue":"5","key":"10.1016\/j.bbi.2026.106957_b0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2020.01.014","article-title":"Depression heterogeneity and its biological underpinnings: toward immunometabolic depression","volume":"88","author":"Milaneschi","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2026.106957_b0205","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1038\/s41380-021-01188-w","article-title":"Association of inflammation with depression and anxiety: evidence for symptom-specificity and potential causality from UK Biobank and NESDA cohorts","volume":"26","author":"Milaneschi","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2026.106957_b0215","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1176\/appi.ajp.20250289","article-title":"Advancing an inflammatory subtype of major depression","volume":"182","author":"Miller","year":"2025","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2026.106957_b0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits: review: cytokine targets in the brain","volume":"30","author":"Miller","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.bbi.2026.106957_b0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbi.2025.01.002","article-title":"Advancing precision psychiatry and targeted treatments: Insights from immunopsychiatry","volume":"125","author":"Miller","year":"2025","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbi.2026.106957_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000217","article-title":"Guidance for developers of health research reporting guidelines","volume":"7","author":"Moher","year":"2010","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.bbi.2026.106957_b0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106957_b0245","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.bbi.2020.12.005","article-title":"Inflammatory phenotype of depression symptom structure: a network perspective","volume":"93","author":"Moriarity","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.bbi.2026.106957_b0250","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1038\/s41380-022-01582-y","article-title":"The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysis","volume":"27","author":"Morrens","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2026.106957_b0255","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41380-019-0471-8","article-title":"Effects of immunomodulatory drugs on depressive symptoms: a mega-analysis of randomized, placebo-controlled clinical trials in inflammatory disorders","volume":"25","author":"MRC ImmunoPsychiatry Consortium","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2026.106957_b0260","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2026.106957_b0265","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","article-title":"Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls","volume":"87","author":"Osimo","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.bbi.2026.106957_b0270","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamapsychiatry.2025.0801","article-title":"Simvastatin as add-on treatment to escitalopram in patients with major depression and obesity: a randomized clinical trial","volume":"82","author":"Otte","year":"2025","journal-title":"JAMA Psychiat."},{"issue":"1\u20133","key":"10.1016\/j.bbi.2026.106957_b0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.schres.2014.05.001","article-title":"Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder","volume":"157","author":"Pearlman","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2026.106957_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2024.101166","article-title":"Immuno-metabolic depression: from concept to implementation","volume":"48","author":"Penninx","year":"2025","journal-title":"Lancet Regional Health - Europe"},{"issue":"6","key":"10.1016\/j.bbi.2026.106957_b0290","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1176\/appi.ajp.2020.20060947","article-title":"Elevated C-reactive protein in patients with depression, independent of genetic, health, and psychosocial factors: results from the UK Biobank","volume":"178","author":"Pitharouli","year":"2021","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0295","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41398-024-02921-z","article-title":"Inflammatory mediators in major depression and bipolar disorder","volume":"14","author":"Poletti","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2026.106957_b0300","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbi.2024.02.019","article-title":"Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: safety, efficacy, and immunological biomarkers","volume":"118","author":"Poletti","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2026.106957_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105425","article-title":"Major depressive disorder as a neuro-immune disorder: origin, mechanisms, and therapeutic opportunities","volume":"155","author":"R\u00e9us","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0315","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S0033291700035558","article-title":"The inventory of depressive symptomatology (IDS): psychometric properties","volume":"26","author":"Rush","year":"1996","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2026.106957_b0310","doi-asserted-by":"crossref","unstructured":"Rush, A. J., Carmody, T., & Reimitz, P.-E. (2000). The inventory of depressive symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. 45\u201359.","DOI":"10.1002\/mpr.79"},{"issue":"5","key":"10.1016\/j.bbi.2026.106957_b0320","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0325","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41380-021-01381-x","article-title":"A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials","volume":"27","author":"Sforzini","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2026.106957_b0335","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/PSY.0b013e31820ad12b","article-title":"Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research","volume":"73","author":"Stetler","year":"2011","journal-title":"Psychosom. Med."},{"issue":"10","key":"10.1016\/j.bbi.2026.106957_b0340","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2026.106957_b0345","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jad.2018.12.037","article-title":"Inflammatory profiles of severe treatment-resistant depression","volume":"246","author":"Strawbridge","year":"2019","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0330","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41380-022-01905-z","article-title":"Immune cell composition in unipolar depression: a comprehensive systematic review and meta-analysis","volume":"28","author":"S\u00f8rensen","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0350","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1037\/a0028813","article-title":"Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia","volume":"121","author":"Treadway","year":"2012","journal-title":"J. Abnorm. Psychol."},{"issue":"4","key":"10.1016\/j.bbi.2026.106957_b0355","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41380-024-02751-x","article-title":"A randomized proof-of-mechanism trial of TNF antagonism for motivational deficits and related corticostriatal circuitry in depressed patients with high inflammation","volume":"30","author":"Treadway","year":"2025","journal-title":"Mol. Psychiatry"},{"issue":"08","key":"10.1016\/j.bbi.2026.106957_b0360","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis c: a systematic review and meta-analysis","volume":"73","author":"Udina","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0365","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41398-020-00920-4","article-title":"Basal and LPS-stimulated inflammatory markers and the course of individual symptoms of depression","volume":"10","author":"Van Eeden","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2026.106957_b0370","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S2215-0366(23)00438-8","article-title":"Heterogeneity of outcome measures in depression trials and the relevance of the content of outcome measures to patients: a systematic review","volume":"11","author":"Veal","year":"2024","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2026.106957_b0375","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1192\/bjp.2023.148","article-title":"Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials","volume":"224","author":"Vreijling","year":"2024","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2026.106957_b0380","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/schbul\/sbx035","article-title":"Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression","volume":"44","author":"Wang","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"Suppl. 1","key":"10.1016\/j.bbi.2026.106957_bib411","article-title":"Stratified and individual participant data meta-analyses to optimise inflammation-based treatment selection in depression: a study within the ASPIRE consortium","volume":"5","author":"Wessa","year":"2026","journal-title":"Neurosci. Appl."},{"key":"10.1016\/j.bbi.2026.106957_bib412","unstructured":"Wessa, C., Vai, B., Foley, \u00c9.M., Delli Colli, C., Simon, M.S., Litvinenko, E., Lamers, F., Lombardo, G., Morrens, M., Gold, S.M., Sforzini, L., Benedetti, F., Felger, J.C., Baune, B.T., Penninx, B.W.J.H., Cattaneo, A., Leboyer, M., Miller, A.H., Mondelli, V., Stein, D., Hoffman, N., Van der Eycken, E., M\u00e4ntyl\u00e4, F.-L., Worrell, C., Woods, A., Pariante, C.M., ASPIRE Study Consortium, De Picker, L., Under review. Evaluation of immune-targeted treatments for depressive symptoms within the precision psychiatry framework: a systematic review and meta-analysis from ASPIRE.."},{"key":"10.1016\/j.bbi.2026.106957_b0385","unstructured":"Williams, J., Link, M., Rosenthal, N., Amira, L., Terman, M. (1992). Structured interview guide for the hamilton rating scale for depression-seasonal affective disorder version (SIGH-SAD)."},{"key":"10.1016\/j.bbi.2026.106957_b0390","unstructured":"World Health Organization. (2022). ICD-11: International classification of diseases (11th revision) (11a ed.)."},{"issue":"4","key":"10.1016\/j.bbi.2026.106957_b0395","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S2215-0366(25)00308-6","article-title":"Anti-inflammatories for depression: challenges and ASPIRations","volume":"13","author":"Worrell","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.bbi.2026.106957_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107322","article-title":"\u201cInflamed\u201d depression: a review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression","volume":"207","author":"Yin","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.bbi.2026.106957_b0405","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/mp.2016.16","article-title":"Isoform switching of steroid receptor co-activator-1 attenuates glucocorticoid-induced anxiogenic amygdala CRH expression","volume":"21","author":"Zalachoras","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2026.106957_b0410","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126007051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159126007051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:27:14Z","timestamp":1791653234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159126007051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":81,"alternative-id":["S0889159126007051"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106957","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Delphi-method-based consensus for clinical domains and assessment of the inflammatory subtype of major depressive disorder from the ASPIRE study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106957"}}